Buttigliero, C., Shepherd, F. A., Barlesi, F., Schwartz, B., Orlov, S., Favaretto, A. G., . . . Scagliotti, G. V. (2018). Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non‐Small Cell Lung Cancer. Oncologist.
Citação norma ChicagoButtigliero, Consuelo, et al. "Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib Plus Placebo With Erlotinib Plus Tivantinib (MARQUEE) in Previously Treated Patients With Advanced Non‐Small Cell Lung Cancer." Oncologist 2018.
Citação norma MLAButtigliero, Consuelo, et al. "Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib Plus Placebo With Erlotinib Plus Tivantinib (MARQUEE) in Previously Treated Patients With Advanced Non‐Small Cell Lung Cancer." Oncologist 2018.